Skip Navigation
Skip to contents



13 results

An Ependymal Cyst in Cerebello-Pontine Angle Presenting with Syncope

Park BJ, Kim YI, Jeun SS, Lee YS

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):121-123.
  • doi: 10.14791/btrt.2013.1.2.121
Intracranial ependymal cysts are rare, congenital, benign lesions. These commonly occur in the supratentorial regions and usually generate no symptoms. The cerebellopontine angle (CPA) is an extremely rare site for...
Primary Spinal Cord Melanoma in Thoracic Spine with Leptomeningeal Dissemination and Presenting Hydrocephalus

Jeong DH, Lee CK, You NK, Kim SH, Cho KH

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):116-120.
  • doi: 10.14791/btrt.2013.1.2.116
Primary spinal cord melanoma is a rare central nervous system malignant tumor. Usually it resembles an intradural extramedullary (IDEM) nerve sheath tumor or melanoma. We experienced a patient with upper...
Pituitary Apoplexy Mimicking Meningitis

Oh K, Kim JH, Choi JW, Kang JK, Kim SH

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):111-115.
  • doi: 10.14791/btrt.2013.1.2.111
Pituitary apoplexy is a rare but life-threatening disorder. Clinical presentation of this condition includes severe headaches, impaired consciousness, fever, visual disturbance, and variable ocular paresis. The clinical presentation of meningeal...
Fulminant Meningitis after Radiotherapy for Clival Chordoma

Kim SM, Park HW, Park MS, Chung SY, Park KS, Lee DS, Oh JT

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):107-110.
  • doi: 10.14791/btrt.2013.1.2.107
The best treatment for clival chordoma is obtained with total surgical excision, sometimes combined with adjuvant radiotherapy. A cerebrospinal fluid (CSF) fistula is a fatal complication that may occur following...
A Case of Multiple Myeloma with Brain Parenchyme Involvement

Yi HJ, Hwang HS, Moon SM, Shin IY, Choi YH

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):103-106.
  • doi: 10.14791/btrt.2013.1.2.103
Multiple myelomas (MM) are characterized by monoclonal proliferation of immunoglobulin (Ig)-secreting plasma cells. Central nervous system involvement is a rare complication of MM, and it can present as either an...
Extremely Delayed Brain Metastasis from Renal Cell Carcinoma

Choi WH, Koh YC, Song SW, Roh HG, Lim SD

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):99-102.
  • doi: 10.14791/btrt.2013.1.2.99
Brain metastasis occurs in 3.9-24% of patients with renal cell carcinoma (RCC), with an average interval from nephrectomy to brain metastasis of 1 to 3 years. A few cases have...
Hemangiopericytoma of the Posterior Fossa: A Case Report and Review of the Literature

Seo I, Kim YS, Kim HS, Kim JH, Lee MK

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):95-98.
  • doi: 10.14791/btrt.2013.1.2.95
Intracranial hemangiopericytoma is unusual, and those occurring in the posterior fossa is extremely rare; we report such a rare case of hemangiopericytoma of the posterior fossa. The radiologic findings and...
Primary Intracranial Fibrosarcoma Presenting with Hemorrhage

Lee JG, Song SW, Koh YC, Cho J, Choi JW, Roh HG, Lim SD

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):91-94.
  • doi: 10.14791/btrt.2013.1.2.91
Primary intracranial fibrosarcomas (PIFs) are extremely rare and the origin of these tumors is still controversial. The rarity of primary intracranial fibrosarcomas makes it difficult to diagnose them correctly and...
Long Term Clinical Outcomes of Malignant Meningiomas

Lim YS, Kim MK, Park BJ, Kim TS, Lim YJ

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):85-90.
  • doi: 10.14791/btrt.2013.1.2.85
OBJECTIVE: Malignant meningiomas are rare and have worse prognosis than benign meningiomas. We report our experience of a malignant meningioma and review relevant literature in an attempt to investigate the...
Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy

Park TY, Na YC, Lee WH, Kim JH, Chang WS, Jung HH, Chang JH, Chang JW, Park YG

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):78-84.
  • doi: 10.14791/btrt.2013.1.2.78
OBJECTIVE: Although metastasis of hepatocellular carcinoma to the brain is uncommon, it is associated with a very high mortality rate and most patients usually expire within 1 year after brain...
Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience

Cho KR, Jo KI, Shin HJ

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):71-77.
  • doi: 10.14791/btrt.2013.1.2.71
OBJECTIVE: The objective of this study was to describe and characterize the clinical course of treatment for invasive prolactinoma patients using bromocriptine. METHODS: The study group included 23 patients who were...
Outcome of Surgical Resection of Symptomatic Cerebral Lesions in Non-Small Cell Lung Cancer Patients with Multiple Brain Metastases

Hong N, Yoo H, Gwak HS, Shin SH, Lee SH

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):64-70.
  • doi: 10.14791/btrt.2013.1.2.64
OBJECTIVE: Patients with symptomatic brain metastases secondary to mass effect are often candidates for surgery. However, many of these surgical candidates are also found to have multiple asymptomatic tumors. This...
Pyruvate Dehydrogenase Kinase as a Potential Therapeutic Target for Malignant Gliomas

Jha MK, Suk K

  • Brain Tumor Res Treat.
  • 2013 Oct;1(2):57-63.
  • doi: 10.14791/btrt.2013.1.2.57
Metabolic aberrations in the form of altered flux through key metabolic pathways are the major hallmarks of several life-threatening malignancies including malignant gliomas. These adaptations play an important role in...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: